Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cotter

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Cancers|November 9, 2024
Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by DermatologistsAlexander M Witkowski, Joshua Burshtein, Michael Christopher, et al.
Journal of Psychiatric Research|February 19, 2026
A systematic review identifying personally modifiable factors for self-harm recovery in young people and the barriers and facilitators to their implementationDavid McEvoy, Colm Sweeney, Leona Ryan, et al.
Brain, Behavior, and Immunity|March 28, 2022
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trialSubash Raj Susai, David Mongan, Colm Healy, et al.
HRB Open Research|January 23, 2026
Barriers and enablers to implementing capacity-strengthening initiatives for public and patient involvement in mental health research: a scoping review protocol informed by the Consolidated Framework for Implementation ResearchShaakya Anand-Vembar, Brian Keogh, Agnes Higgins, et al.
Translational Psychiatry|October 28, 2022
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosisSubash Raj Susai, Colm Healy, David Mongan, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
Communications Biology|February 25, 2026
Characterising a stress-sensitive default mode network (DMN) deficit in major psychiatric disordersSinead King, Zuo Zhang, Lauren Robinson, et al.
Schizophrenia (Heidelberg, Germany)|May 21, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerationsDiana O Perkins, Clark D Jeffries, Scott R Clark, et al.
Schizophrenia Bulletin|March 7, 2024
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for PsychosisCassandra M J Wannan, Barnaby Nelson, Jean Addington, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Cancers|November 9, 2024
Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by DermatologistsAlexander M Witkowski, Joshua Burshtein, Michael Christopher, et al.
Journal of Psychiatric Research|February 19, 2026
A systematic review identifying personally modifiable factors for self-harm recovery in young people and the barriers and facilitators to their implementationDavid McEvoy, Colm Sweeney, Leona Ryan, et al.
Brain, Behavior, and Immunity|March 28, 2022
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trialSubash Raj Susai, David Mongan, Colm Healy, et al.
HRB Open Research|January 23, 2026
Barriers and enablers to implementing capacity-strengthening initiatives for public and patient involvement in mental health research: a scoping review protocol informed by the Consolidated Framework for Implementation ResearchShaakya Anand-Vembar, Brian Keogh, Agnes Higgins, et al.
Translational Psychiatry|October 28, 2022
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosisSubash Raj Susai, Colm Healy, David Mongan, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
Communications Biology|February 25, 2026
Characterising a stress-sensitive default mode network (DMN) deficit in major psychiatric disordersSinead King, Zuo Zhang, Lauren Robinson, et al.
Schizophrenia (Heidelberg, Germany)|May 21, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerationsDiana O Perkins, Clark D Jeffries, Scott R Clark, et al.
Schizophrenia Bulletin|March 7, 2024
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for PsychosisCassandra M J Wannan, Barnaby Nelson, Jean Addington, et al.
Pageof 10